Qiagen N.V.
NYSEQIAGEN entered its Q1 2026 earnings week already nursing a 17% one-month decline. The report did nothing to arrest the slide — and the Street's response was swift and unanimous. Q1 sales came in at $492m, missing the $498m consensus estimate. Adjusted EPS of $0.54 matched expectations, but the forward picture was the real damage. Full-year 2026 EPS guidance was trimmed to at least…
Snapshot as of 7 May 2026
QIAGEN entered its Q1 2026 earnings week already nursing a 17% one-month decline. The report did nothing to arrest the slide — and the Street's response was swift and unanimous. Q1 sales came in at $492m, missing the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for QGEN — free to start on ORTEX.
Sign up for free →Open QGEN on ORTEX